Recently, Rainbow successfully obtained the first formulation registration in the European Union, its Clethodim EC has been registered in Poland and will be approved in Spain and other more countries.

Since the acquisition of Exclusivas Sarabia, Rainbow is rapidly integrating its product system and marketing network based on a clear strategic plan of the EU market. This first formulation registration will strengthen Rainbow team’s confidence in the EU market strategic plan and will accelerate the pace of expanding the EU market.

Since 2016, Rainbow has been investing in pesticide technical equivalences in the European Union. It has now obtained the equivalent identification of about 80 active components in the EU, and more A.I.s are in progress. At present, Rainbow has carried out nearly 10 formulation products registration, and decided to continue to increase the investment to screen for important active ingredients and to invest in Annex II Defending & Annex III for marketable formulations in the EU market.

It is expected that the continuous increase of investment in the EU market will lay a solid foundation for Rainbow's sustained growth in 2025-2030.